full list rate price target
earn chang report pleas see
tabl page
short cycl updat
worri estim
provid quick updat short cycl stock coverag light
enter upturn sharp valuat de-rat
favor stock sinc initi feb rel valuat
multipl compress appear unlik given trade rel
compar point prior upturn henc risk center ep estim
lower forecast price slightli sever stock ph
yet see enough compel evid forecast outright
declin short cycl sale year end also provid data organ
sale share price perform valuat gdi ph
well although portfolio chang arguabl de-coupl
classic short cycl name current upturn prior recent
upturn data permit found compar upturn approach
use forecast posit earli neg earli inflect
ism new order drop least shoe less room drop note us
multi commentari data point holiday period jan us manufactur
data start deterior recent month ism data underscor
soften histor data suggest short cycl stock outperform
quarter follow short cycl upturn requir organ sale
growth ism amongst data point suggest rate growth look
increasingli unlik look recent ism move two differ lens
ism new order magnitud declin magnitud greater point period
look back prior ism new order declin greater see
averag short cycl organ sale growth reach follow
month howev note two period late late
declin dec y-o-i organ sale turn neg
absolut ism level new order declin new order index move
time sinc jan two instanc
averag short cycl growth reach follow month may give
encourag although period preced recess
month follow two period mid late short cycl
organ sale trend subsequ end turn neg
cycl longev three prior short cycl organ sale upturn last quarter
averag current march repres current upturn
valuat short cycl name year trade histori averag
trade price-to-earnings multipl discount rel point quarter
prior upturn stock look cheap rel compar point prior upturn
discount ph discount valuat assum cours
current estim denomin broadli accur point
worth note last time ism new order index feb
short cycl share price averag lower today biggest
downsid ph
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
summari rate price target earn chang report chang shown bold
barclay research share price target price shown primari list currenc ep estim shown report currenc
current fiscal year estim barclay research fiscal year estim barclay research
short cycl valuat multipl de-rat significantli in-lin
compar point previou upturn
organ sale growth roughli in-lin compar point prior upturn
absolut valuat multipl compress significantli unlik
declin
rel share price perform lag prior upturn significantli
valuat multipl trough also look hand rel standpoint
appear much upsid potenti revers
averag rel valuat seen compar point prior upturn
downsid
prior upturn
notabl except
downsid
prior upturn
price-to-earnings rel
ism new order declin implic short cycl organ growth
chang ism look previou steep ism new order declin averag
organ sale growth twelv month follow usual posit
expect current ism drop presag neg organ sale
howev usual deceler organ sale growth expect
deceler occur
end drop
start drop
magnitud ism new order drop
barclay research compani data bloomberg analyt organ sale growth averag taken
degre deceler organ sale growth vari consider
follow ism new order fall
barclay research compani data bloomberg analyt organ growth averag estim
start drop
end drop
magnitud ism new order drop
barclay research compani data bloomberg analyt organ sale growth averag taken
absolut ism averag organ sale manag grow follow
period ism new order hit way jan
barclay research compani data bloomberg analyt organ growth averag estim
short cycl organ sale trend estim deceler
barclay research compani data upturn length dec quarter ph sep growth use fy growth jun sep growth use fy growth
length upturn longer look brief compar histori
length
upturn
period far inc
abbrevi upturn due thai flood gdi public
histori suggest difficult stock outperform late
price-to-earnings rel current vs previou upturn
out-performance short cycl stock quarter dec current upturn upturn typic requir organ sale growth
previou cyclic upturn seem impli
organ sale growth greater
estim next three
quarter need short cycl stock
averag organ sale chang next quarter
upturn prolong growth fairli high rate growth
upturn short shallow slump overwhelm exc-
upturn steep bounc earli steadi deceler
current upturn sinc amplitud growth resembl
short cycl tracker indic notabl demand deceler
order organicemr orderscat machin sale -nafast salescat machin sale -apacteco saleshiwin salesjmtba total oversea ordersamt ordersu cut tool ordersconveyor equip orders-north americaiata total freight ebci current conditionsebci futur conditionsu ismu ism new ordersu capac utilizationu durabl good order ex tran ex defens yoy us factori order exc transport yoy us ip yoy germani factori order yoy south korea export yoy china manufactur parti vs vs vs vs vs vs vs vs vs vs vs vs vs vs vs vs -ve data point short-cyl industri product organ sale growth short cycl tracker posit data point barclay multi-industri
share price perform vs prior short cycl recoveri
share price perform vs prior short cycl recoveri
share price perform vs prior short cycl recoveri
share price perform vs prior short cycl recoveri
share price perform vs
share price perform vs prior short cycl recoveri
share price perform vs prior short cycl recoveri
share price perform vs prior short cycl recoveri
share price perform vs prior short cycl recoveri
margin return data
balanc sheet cash flow mn
equival
short long-term debt
flow oper
valuat leverag metric
underweight manag execut well
cost increment margin
low hurdl given histori cost
pressur flexibl spin
asset tax-fre five-year restrict expir
think manag retain current
structur littl upsid sotp ebitda
stronger-than-expect rebound would
moder non-residenti growth linger
equal weight order growth slow
expect organ sale moder
shown capabl outperform peer
oper period decreas demand
expect valuat multipl de-rat in-lin
compar period prior cycl
togeth continu growth rs
increment capit deploy top base
moderate-than-expect growth particularli
increment capit deploy top base case
margin return data
balanc sheet cash flow mn
equival
short long-term debt
flow oper
valuat leverag metric
equal weight top line growth like
moder initi -stage upturn
larg behind us encourag
restructur effort compani boost margin
expans higher capital-expenditure modern
manufactur footprint medium-term
short-cycl industri acceler well higher
volum increment particularli industri
short-cycl industri slowdown well slightli
lower increment across compani
margin return data
balanc sheet cash flow mn
equival
short long-term debt
flow oper
valuat leverag metric
margin return data
balanc sheet cash flow mn
equival
short long-term debt
flow oper
valuat leverag metric
overweight think upsid
near-term financi guidanc well medium-
term consensu estim base histori
magnitud rel under-perform
 like limit
assum ph deploy organ growth halv
current level increment margin
consist exc-r gross margin impli
ep possibl share price
moder short-cycl organ sale growth
continu product ineffici
margin return data
balanc sheet cash flow mn
equival
short long-term debt
flow oper
valuat leverag metric
deceler potenti tailwind iot
exposur overestim mani margin upsid
may cap rise invest need amidst
increas competit industri rival
rais buy-back guid see limit
option balanc sheet
stronger-than-expect rebound heavi industri
end market combin sustain semi
sharp turn auto semi end market
valuat methodolog risk
valuat methodolog underweight rate target price predic upon follow methodolog dcf growth
risk may imped achiev barclay research valuat price above-sector averag exposur
raw materi inflat non-residenti construct cycl present possibl profit top-lin risk medium term
valuat methodolog equal weight rate target price predic upon follow methodolog dcf growth
risk may imped achiev barclay research valuat price risk includ inabl execut
expand margin due acquisit cost well reinvest back busi also averag exposur china
may creat headwind given current trade environ upsid risk oil price see sharp increas boost outlook
valuat methodolog equal weight rate target price predic upon follow methodolog dcf through-cycl
risk may imped achiev barclay research valuat price risk includ slowdown gener industri
product alongsid greater structur pressur increas penetr addit manufactur electr vehicl distributor
disrupt stem e-commerc
valuat methodolog overweight rate target price predic upon follow methodolog dcf growth
risk may imped achiev barclay research valuat price risk price target rate includ
short-cycl industri slowdown moder aerospac recoveri failur achiev expect clarcor synergi
valuat methodolog equal weight rate target price predic upon follow methodolog dcf sale compound-annual-growth-rate
om wacc ev/ebitda price-to-earnings yield well mark market stake
risk may imped achiev barclay research valuat price sale gener auto
end market larg growth driver compani recent year quicker expect turn vertic would pose
risk top-lin growth
julian mitchel herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
